Skip to main content
. 2017 Jun 3;8(26):41841–41853. doi: 10.18632/oncotarget.18360

Figure 3. Kinetics of B16ova tumor growth.

Figure 3

C57Bl/6 (wt) and Cblb−/− mice were s.c. injected with 5×105 B16ova cells and i.p. injected with 500μg anti-PD-L1 or IgG control antibody every 3rd day starting on day 0. The data are pooled from two independent experiments (n = 6-8 per group). Tumor volume is shown.